Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Kidney Transplantation

  Free Subscription


Articles published in J Urol

Retrieve available abstracts of 65 articles:
HTML format



Single Articles


    July 2021
  1. GOLDFARB DA
    Renal Transplantation and Renovascular Hypertension.
    J Urol. 2021 Jul 20:101097JU0000000000002114. doi: 10.1097/JU.0000000000002114.
    PubMed    


    May 2021
  2. GOLDFARB DA
    Renal Transplantation and Renovascular Hypertension.
    J Urol. 2021 May 12:101097JU0000000000001852. doi: 10.1097/JU.0000000000001852.
    PubMed    


    April 2021
  3. GOLDFARB DA
    Renal Transplantation and Renovascular Hypertension.
    J Urol. 2021 Apr 21:101097JU0000000000001801. doi: 10.1097/JU.0000000000001801.
    PubMed    


  4. GOLDFARB DA
    Renal Transplantation and Renovascular Hypertension.
    J Urol. 2021 Apr 1:101097JU0000000000001723. doi: 10.1097/JU.0000000000001723.
    PubMed    


    February 2021
  5. GOLDFARB DA
    Renal Transplantation and Renovascular Hypertension.
    J Urol. 2021 Feb 24:101097JU0000000000001663. doi: 10.1097/JU.0000000000001663.
    PubMed    


    January 2021
  6. GOLDFARB DA
    Renal Transplantation and Renovascular Hypertension.
    J Urol. 2021 Jan 21:101097JU0000000000001610. doi: 10.1097/JU.0000000000001610.
    PubMed    


    December 2020
  7. GOLDFARB DA
    Renal Transplantation and Renovascular Hypertension.
    J Urol. 2020 Dec 23:101097JU0000000000001540. doi: 10.1097/JU.0000000000001540.
    PubMed    


  8. PYRGIDIS N, Mykoniatis I, Sokolakis I, Minopoulou I, et al
    Renal Transplantation Improves Erectile Function in Patients with End-Stage Renal Disease: A Systematic Review and Meta-Analysis.
    J Urol. 2020 Dec 15:101097JU0000000000001577. doi: 10.1097/JU.0000000000001577.
    PubMed     Abstract available


    November 2020
  9. GOLDFARB DA
    Renal Transplantation and Renovascular Hypertension.
    J Urol. 2020 Nov 6:101097JU0000000000001491. doi: 10.1097/JU.0000000000001491.
    PubMed    


  10. GOLDFARB DA
    Renal Transplantation and Renovascular Hypertension.
    J Urol. 2020 Nov 2:101097JU0000000000001460. doi: 10.1097/JU.0000000000001460.
    PubMed    


    September 2020
  11. GOLDFARB DA
    Re: Impact of Donor Hepatitis C Virus on Kidney Transplant Outcomes for Hepatitis C-Positive Recipients in the Direct-Acting Antiviral Era: Time to Revise the Kidney Donor Risk Index?
    J Urol. 2020 Sep 21:101097JU0000000000001277. doi: 10.1097/JU.0000000000001277.
    PubMed    


  12. AHLAWAT R, Sood A, Jeong W, Ghosh P, et al
    Robotic Kidney Transplantation with Regional Hypothermia Versus Open Kidney Transplantation for Patients with End-Stage Renal Disease: An Ideal Stage 2B Study.
    J Urol. 2020 Sep 16:101097JU0000000000001368. doi: 10.1097/JU.0000000000001368.
    PubMed     Abstract available


    August 2020
  13. GOLDFARB DA
    Re: Impact of Tocilizumab (Anti-IL-6R) Treatment on Immunoglobulins and Anti-HLA Antibodies in Kidney Transplant Patients with Chronic Antibody-Mediated Rejection.
    J Urol. 2020 Aug 21:101097JU0000000000001255. doi: 10.1097/JU.0000000000001255.
    PubMed    


    July 2020
  14. GOLDFARB DA
    Re: Ultra-Short Duration Direct Acting Antiviral Prophylaxis to Prevent Virus Transmission from Hepatitis C Viremic Donors to Hepatitis C Negative Kidney Transplant Recipients.
    J Urol. 2020 Jul 23:101097JU0000000000001214. doi: 10.1097/JU.0000000000001214.
    PubMed    


    June 2020
  15. GOLDFARB DA
    Re: Covid-19 and Kidney Transplantation.
    J Urol. 2020 Jun 26:101097JU000000000000117001.
    PubMed    


  16. GOLDFARB DA
    Re: Practical Considerations for APOL1 Genotyping in the Living Kidney Donor Evaluation.
    J Urol. 2020;203:1051-1052.
    PubMed    


    May 2020
  17. CANNING DA
    Re: Long-Term Outcome of Pediatric Renal Transplantation in Boys with Posterior Urethral Valves.
    J Urol. 2020 May 14:101097JU000000000000110801.
    PubMed    


  18. CANNING DA
    Re: Long-Term Outcomes of Pediatric Kidney Transplant Recipients with a Pretransplant Malignancy.
    J Urol. 2020 May 14:101097JU000000000000110802.
    PubMed    


  19. GOLDFARB DA
    Re: Long-Term Outcome of Renal Transplantation in Patients with Congenital Lower Urinary Tract Malformations: A Multicenter Study.
    J Urol. 2020 May 12:101097JU0000000000001109. doi: 10.1097/JU.0000000000001109.
    PubMed    


  20. GOLDFARB DA
    Re: Impact of Pre-Transplant Malignancy on Outcomes after Kidney Transplantation: United Network for Organ Sharing Database Analysis.
    J Urol. 2020 May 12:101097JU000000000000110901.
    PubMed    


    April 2020
  21. GOLDFARB DA
    Re: Different Outcomes after Kidney Transplantation between African Americans and Whites: A Matter of Income? A Single-Center Study.
    J Urol. 2020 Apr 2:101097JU0000000000001050. doi: 10.1097/JU.0000000000001050.
    PubMed    


    February 2020
  22. LORENZO AJ
    Editorial Comment.
    J Urol. 2020;203:412.
    PubMed    


  23. KROPP B
    Editorial Comment.
    J Urol. 2020;203:412.
    PubMed    


    December 2019
  24. RESNICK MJ
    Re: Association between Dialysis Facility Ownership and Access to Kidney Transplantation.
    J Urol. 2019 Dec 3:101097JU000000000000067201.
    PubMed    


  25. GOLDFARB DA
    Re: Impact of Aortoiliac Stenosis on Graft and Patient Survival in Kidney Transplant Recipients Using the TASC II Classification.
    J Urol. 2019 Dec 3:101097JU0000000000000671. doi: 10.1097/JU.0000000000000671.
    PubMed    


  26. GOLDFARB DA
    Re: Using Computer-Assisted Morphometrics of 5-Year Biopsies to Identify Biomarkers of Late Renal Allograft Loss.
    J Urol. 2019 Dec 3:101097JU000000000000067101.
    PubMed    


    October 2019
  27. SCHAEFFER EM
    Re: Renal Transplant Recipients Receiving Loop Diuretic Therapy Have Increased Urinary Tract Infection Rate and Altered Medullary Macrophage Polarization Marker Expression.
    J Urol. 2019 Oct 21:10109701JU000061149295835.
    PubMed    


    September 2019
  28. GOLDFARB DA
    Re: Outcomes in Third and Fourth Kidney Transplants Based on the Type of Donor.
    J Urol. 2019 Sep 13:101097JU0000000000000547. doi: 10.1097/JU.0000000000000547.
    PubMed    


  29. GOLDFARB DA
    Re: Prospective, Double-Blind, Randomized Clinical Trial Comparing an ERAS Pathway with Ketorolac and Pregabalin versus Standard of Care plus Placebo during Live Donor Nephrectomy for Kidney Transplant.
    J Urol. 2019 Sep 13:10109701JU0000585200727826.
    PubMed    


  30. JAHROMI MS, Velasquez MC, Blachman-Braun R, Gosalbez R, et al
    Pediatric Kidney Transplant Outcomes in Children with Primary Urologic Abnormalities Compared to Children with Non-urologic Abnormalities: Long-Term Results.
    J Urol. 2019 Sep 5:101097JU0000000000000528. doi: 10.1097/JU.0000000000000528.
    PubMed     Abstract available


    August 2019
  31. GOLDFARB DA
    Re: Antibiotic Prophylaxis for Ureteral Stent Removal after Kidney Transplantation.
    J Urol. 2019 Aug 8:101097JU0000000000000483. doi: 10.1097/JU.0000000000000483.
    PubMed    


  32. GOLDFARB DA
    Re: Donor Organ Intervention before Kidney Transplantation: Head-to-Head Comparison of Therapeutic Hypothermia, Machine Perfusion, and Donor Dopamine Pretreatment. What is the Evidence?
    J Urol. 2019 Aug 8:10109701JU00005797162797940.
    PubMed    


    July 2019
  33. GOLDFARB DA
    Re: Outcome of Sirolimus-Based Immunosuppression, Fifteen Years Post-Live-Donor Kidney Transplantation: Single-Center Experience.
    J Urol. 2019 Jul 8:101097JU0000000000000425. doi: 10.1097/JU.0000000000000425.
    PubMed    


    June 2019
  34. CHANG SS
    Re: Disseminated Mycobacterium bovis Infection Post-Kidney Transplant following Remote Intravesical BCG Therapy for Bladder Cancer.
    J Urol. 2019 Jun 10:101097JU0000000000000381. doi: 10.1097/JU.0000000000000381.
    PubMed    


  35. BOWEN DK
    Editorial Comment.
    J Urol. 2019;201:1205.
    PubMed    


    March 2019
  36. KROPP BP
    Measuring Competency and Learning Curve for Pediatric Renal Transplant.
    J Urol. 2019 Mar 18:101097JU0000000000000239. doi: 10.1097/JU.0000000000000239.
    PubMed    


  37. GOLDFARB DA
    Re: Minimally Invasive, Robot-Assisted Procedure for Kidney Transplantation among Morbidly Obese: Positive Outcomes at 5 Years Post-Transplant.
    J Urol. 2019 Mar 13:101097JU0000000000000219. doi: 10.1097/JU.0000000000000219.
    PubMed    


  38. AMINSHARIFI A, Simon R, Polascik TJ, Robertson CN, et al
    Evaluation and active treatment versus active surveillance of localized prostate cancer in renal transplant patients in the era of low and very low risk prostate cancer.
    J Urol. 2019 Mar 5:101097JU0000000000000207. doi: 10.1097/JU.0000000000000207.
    PubMed     Abstract available


  39. GOLDFARB DA
    Re: Cost-Effectiveness of Hepatitis C-Positive Donor Kidney Transplantation for Hepatitis C-Negative Recipients with Concomitant Direct-Acting Antiviral Therapy.
    J Urol. 2019;201:431.
    PubMed    


    February 2019
  40. GOLDFARB DA
    Re: Impact of Ureteral Stricture and Treatment Choice on Long-Term Graft Survival in Kidney Transplantation.
    J Urol. 2019 Feb 1. doi: 10.1097/JU.0000000000000151.
    PubMed    


  41. FEIZI M, Moeindarbari T
    Donor Willingness to Accept Selling a Kidney for Transplantation: Evidence from Iran.
    J Urol. 2019;201:235-236.
    PubMed    


    January 2019
  42. ZAONTZ MR
    The Role of Urology in Today's Pediatric Kidney Transplants.
    J Urol. 2019 Jan 16. doi: 10.1097/JU.0000000000000115.
    PubMed    


  43. GOLDFARB DA
    Re: Inferior Long-Term Allograft and Patient Outcomes among Recipients of Offspring Living Donor Kidneys.
    J Urol. 2019;201:19-20.
    PubMed    


    December 2018
  44. CHUA ME, Ming JM, Kim JK, Degheili J, et al
    Competency and learning curve for pediatric renal transplant using cumulative sum analyses.
    J Urol. 2018 Dec 24. doi: 10.1097/JU.0000000000000021.
    PubMed     Abstract available


    November 2018
  45. SCHAEFFER EM
    Re: Screening for Asymptomatic Bacteruria at One Month after Adult Kidney Transplantation: Clinical Factors and Implications.
    J Urol. 2018;200:925.
    PubMed    


    October 2018
  46. GOLDFARB DA
    Re: A Cost Comparison for Telehealth Utilization in the Kidney Transplant Waitlist Evaluation Process.
    J Urol. 2018;200:687-688.
    PubMed    


    September 2018
  47. MORRISON CD, Shannon R, Rosoklija I, Nettey OS, et al
    Ureteral Complications of Pediatric Renal Transplantation.
    J Urol. 2018 Sep 6. pii: S0022-5347(18)43837-2. doi: 10.1016/j.juro.2018.
    PubMed     Abstract available


  48. GOLDFARB DA
    Re: Race, Risk, and Willingness of End-Stage Renal Disease Patients without Hepatitis C Virus to Accept an HCV-Infected Kidney Transplant.
    J Urol. 2018;200:487-488.
    PubMed    


    June 2018
  49. GOLDFARB DA
    Re: Urologic Malignancies in Kidney Transplantation.
    J Urol. 2018;199:1385-1386.
    PubMed    


    May 2018
  50. GOLDFARB DA
    Re: Robot-Assisted Kidney Transplantation: The European Experience.
    J Urol. 2018;199:1101-1102.
    PubMed    


    April 2018
  51. WEIN AJ
    Re: Dietary Sodium Restriction Reduces Nocturnal Urine Volume and Nocturnal Polyuria Index in Renal Allograft Recipients with Nocturnal Polyuria.
    J Urol. 2018;199:899.
    PubMed    


    January 2018
  52. GOLDFARB DA
    Re: Successful Renal Transplantation in Small Children with a Completely Thrombosed Inferior Vena Cava.
    J Urol. 2018;199:19.
    PubMed    


    December 2017
  53. GOLDFARB DA
    Re: A Cost Comparison for Telehealth Utilization in the Kidney Transplant Waitlist Evaluation Process.
    J Urol. 2017;198:1199.
    PubMed    


  54. GOLDFARB DA
    Re: Telemedically Supported Case Management of Living-Donor Renal Transplant Recipients to Optimize Routine Evidence-Based Aftercare: A Single-Center Randomized Controlled Trial.
    J Urol. 2017;198:1198-1199.
    PubMed    


    November 2017
  55. GOLDFARB DA
    Re: Big Data, Predictive Analytics, and Quality Improvement in Kidney Transplantation: A Proof of Concept.
    J Urol. 2017;198:970.
    PubMed    


  56. GOLDFARB DA
    Re: Remote Ischemic Conditioning on Recipients of Deceased Renal Transplants Does Not Improve Early Graft Function: A Multicenter Randomized, Controlled Clinical Trial.
    J Urol. 2017;198:970.
    PubMed    


    October 2017
  57. GOLDFARB DA
    Re: Continuous Normothermic Ex Vivo Kidney Perfusion is Superior to Brief Normothermic Perfusion following Static Cold Storage in Donation after Circulatory Death Pig Kidney Transplantation.
    J Urol. 2017;198:734.
    PubMed    


    September 2017
  58. GOLDFARB DA
    Re: Calcification Score Evaluation in Patients Listed for Renal Transplantation.
    J Urol. 2017;198:472-473.
    PubMed    


    August 2017
  59. GOLDFARB DA
    Re: Risk of Renal Cell Carcinoma among Kidney Transplant Recipients in the United States.
    J Urol. 2017;198:246.
    PubMed    


  60. GOLDFARB DA
    Re: Are Octogenarians with End-Stage Renal Disease Candidates for Renal Transplantation?
    J Urol. 2017;198:245.
    PubMed    


    June 2017
  61. GOLDFARB DA
    Re: The Changing Financial Landscape of Renal Transplant Practice: A National Cohort Analysis.
    J Urol. 2017;197:1546-1547.
    PubMed    


    May 2017
  62. CANNING DA
    Re: Urological Complications, Vesicoureteral Reflux, and Long-Term Graft Survival Rate after Pediatric Kidney Transplantation.
    J Urol. 2017;197:1355.
    PubMed    


  63. GOLDFARB DA
    Re: Eight-Hour Continuous Normothermic Ex Vivo Kidney Perfusion is a Safe Preservation Technique for Kidney Transplantation: A New Opportunity for the Storage, Assessment, and Repair of Kidney Grafts.
    J Urol. 2017;197:1325.
    PubMed    


  64. GOLDFARB DA
    Re: Coronary Calcium Score May Replace Cardiovascular Risk Factors as Primary Risk Stratification Tool before Kidney Transplantation.
    J Urol. 2017;197:1324-1325.
    PubMed    


    July 2016
  65. ASSIMOS DG
    Re: Predictors of Incident ESRD among Patients with Primary Hyperoxaluria Presenting prior to Kidney Failure.
    J Urol. 2016;196:137-8.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Kidney Transplantation is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: